alpha-aminopyridine has been researched along with Cardio-Cutaneous Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbadessa, G; Chandrasekhar, V; Kontaridis, MI; Schwartz, B; Wang, J; Yu, Y | 1 |
1 other study(ies) available for alpha-aminopyridine and Cardio-Cutaneous Syndrome
Article | Year |
---|---|
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
Topics: Alleles; Aminopyridines; Animals; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Humans; Imidazoles; LEOPARD Syndrome; Male; Mice; Mice, Transgenic; Mutation; Myocytes, Cardiac; Phosphoproteins; Protein Domains; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |